InvestorsHub Logo
Followers 45
Posts 4151
Boards Moderated 0
Alias Born 02/17/2014

Re: chipboarder post# 111167

Monday, 03/20/2017 1:20:10 AM

Monday, March 20, 2017 1:20:10 AM

Post# of 232998
I would further conjecture following:

Cross license agreement (hence continental boundary) is for non-CE only.

Global CE customer can choose Liquidmorphium or Liquidmetal DC-105s (which is the same thing as pointed out by Eontec sales associate at CES this year).

Mfr for CE business must be done by Eontec. If PO is for Liquidmetal, "branding" royalty will be paid by Eontec to LQMT.

Eontec must perform CE business for two reasons.

1. Prevent Liquidmorphium to become CIP asset. Note neither INJ-105s nor DC-105s is CIP asset for non-CE business.
2. CE business is typically high volume.

Apple will have nothing to say on this matter.

I would argue commercialization can only be thru CE segment with or without Apple.

To my best of understanding, Apple agreement did not include the "brand". They bought exclusive right to all CIP containment only. LQMT contribution to CIP is nothing more than INJ-LM105.

If Apple decides to be part of the game for INJ-105s or DC-105s and wants it to be part of the CIP. They must amend the MTA.

If Apple decides against exclusivity, they simply become another Global CE customer to Eontec/LQMT.

Let's hear back from this board where is the "hole" with the above CONJECTURE.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LQMT News